Skip to main content
  • MyUW
  • Calendar
  • Directories
  • Libraries
  • UW Medicine
  • Maps
  • UW Today

Helpful Links

  • Computing/IT
  • Workday HCM
  • Husky Card
  • UW Bothell
  • UW Tacoma
  • UW Facebook
  • UW Twitter
University of Washington
University of Washington
  • Students
  • Parents
  • Faculty & Staff
  • Alumni
  • Home
  • About
    • Mission
    • People
    • Affiliations
  • Projects
    • Pharmacy and Supply Chain Strengthening Program in Malawi
    • Malaria in Pregnancy Consortium – Pharmacovigilance Activities
    • Systems for Improved Access to Pharmaceuticals and Services Program (SIAPS)
    • Assessment of the Safety of Antimalarial Drug Use During Early Pregnancy (ASAP)
    • Pharmacovigilance Strategy & Methods Development
    • Strengthening Pharmaceutical Systems (SPS)
  • Publications
  • Contact Us
  • News
    • News Archive
    • Newsletter Archive
  • Donate
Global Medicines Program
    • Home
    • About
      • Mission
      • People
      • Affiliations
    • Projects
      • Pharmacy and Supply Chain Strengthening Program in Malawi
      • Malaria in Pregnancy Consortium – Pharmacovigilance Activities
      • Systems for Improved Access to Pharmaceuticals and Services Program (SIAPS)
      • Assessment of the Safety of Antimalarial Drug Use During Early Pregnancy (ASAP)
      • Pharmacovigilance Strategy & Methods Development
      • Strengthening Pharmaceutical Systems (SPS)
    • Publications
    • Contact Us
    • News
      • News Archive
      • Newsletter Archive
    • Donate
  • Home
  • Global Medicines Program
  • News
  • Andy Stergachis and Solomon Lubinga profiled in SPH Connect

January 24, 2014

Andy Stergachis and Solomon Lubinga profiled in SPH Connect

Read the article here.

connectJuly2013

Recent News

Landscape analysis of pregnancy exposure registries in low- and middle-income countries

Call to Action on Antimicrobial Resistance held in Ghana

Stergachis co-edited maternal immunization roadmap for Gates Foundation & GAPPS

Team finds no adverse risk to use of common antimalarials in first trimester.

RSS FDA MEDWATCH NEWSFEED

  • Update: FDA Encourages the Public to Follow Established Choking Rescue Protocols - FDA Safety Communication
  • Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of-Specification Endotoxin Results in Certain Reserve Samples
  • Olympus Issues Voluntary Labeling Update for Bronchoscopes Used with Laser Therapy Equipment
  • Otsuka ICU Medical LLC Issues Voluntary Nationwide Recall of 20 mEq Potassium Chloride Injection Due To Overwrap Mislabeled As 10 mEq Potassium Chloride Injection

Make a gift

To make a gift to support the work of the Global Medicines Program, please click here: Donate.

Stay connected

Visit our Facebook page: www.facebook.com/uwglobalrx
University of Washington

Be boundless

Connect with us:

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Accessibility
  • Contact Us
  • Jobs
  • Campus Safety
  • My UW
  • Rules Docket
  • Privacy
  • Terms
  • Newsletter

© 2025 University of Washington | Seattle, WA